UK medical device innovator Mediplus has unveiled its pioneering 5-Way TIVA (Total intravenous anaesthesia) Set at SIVA 2024.
SIVA is the annual scientific meeting hosted by The Society for Intravenous Anaesthesia. Held on 28th and 29th of November 2024 at Cutlers Hall in Sheffield,UK, the event gathers experts from around the world to explore the latest advancements in intravenous anaesthesia.
Gold event sponsor at the SIVA event, Mediplus has graced our pages before. The company tells us its new product is the first of its kind on the market. The innovative set allows clinicians to administer up to four different drugs and an infusion through a single, integrated system. By consolidating multiple drug lines into one streamlined hub, the system simplifies anaesthesia management. Moreover it reduces the risk of leaks and blockages, and enhances overall patient safety.
Previously, managing multiple drugs in TIVA required numerous lines and connection points. This increased the risk of errors and complications. With the new design, the 5-Way TIVA Set eliminates the need for additional lines and taps. The result is a cleaner, safer, and more efficient anaesthesia process. The system features Siamese tubing to prevent tangled lines and includes colour-coded lines for easy identification.
The company points to the new product as representing a significant development in its highly successful range of TIVA sets.
5-Way TIVA Set features
The set features an anti-siphon valve to prevent backflow, as well as an anti-reflux valve to ensure fluid lines remain uncontaminated. Available in lengths of 2.5M and 3M, the 5-Way TIVA Set offers the flexibility to meet diverse clinical needs.
Mediplus continues to prioritise sustainability in its product designs. By reducing the number of lines required and minimising plastic content, the 5-Way TIVA Set contributes to both environmental sustainability and improved performance. This is in line with Mediplus’s ongoing commitment to advancing healthcare while reducing its environmental footprint.
The launch of the 5-Way TIVA Set follows a history of innovation at Mediplus, which has been producing cutting-edge medical devices since its establishment in 1986. The company’s products are trusted across more than 40 countries and continue to set new standards in Critical Care and Pelvic Floor/Urology. Mediplus is also preparing to enter the US market in 2026, pending regulatory approval.
Company comments
Emma Gray at Mediplus, said: “The 5-Way TIVA Set marks a significant leap forward in simplifying anaesthesia procedures and improving patient outcomes. Our goal is to make clinical workflows safer and more efficient, and this set embodies our commitment to that vision. It will not only reduce the complexity of TIVA management but also contribute to improved patient experiences by reducing risks like post-operative nausea and vomiting (PONV).”
Find more information about Mediplus and its range of products at https://www.mediplusuk.com or contact Marketing@medplusuk.com
published: November 29, 2024 in: Anaesthesia, Launches / Withdrawals, UK
